AMREF’s Post

Antimicrobial resistance (AMR) stands as one of the top global public health threat and development challenge, yet there is hope in our collective response. In 2019 alone, bacterial AMR was estimated to be directly responsible for 1.27 million deaths globally and contributed to 4.95 million deaths. Beyond the human cost, AMR presents a significant economic burden. The World Bank projects that by 2050, AMR could result in an additional US$1 trillion in healthcare costs and potential GDP losses of US$1 trillion to US$3.4 trillion per year by 2030. This challenge spans all regions and income levels, with a disproportionate impact on low- and middle-income countries. AMR jeopardizes many of the advances of modern medicine, making infections harder to treat and medical procedures, like surgery and cancer treatment, more complex and risky. The overuse and misuse of antimicrobials across humans, animals, and plants drive the rise of drug-resistant pathogens. Afya Plus reaffirms its commitment to support building of resilient local systems to reduce the AMR burden. Our focus includes preventing infections that lead to unnecessary antimicrobial use, ensuring universal access to quality diagnostics, and implementation of effective policies and surveillance systems to guide AMR control efforts. We are committed to raising public awareness, advocating for relevant legislation, and operationalization of the national action plans through “One Health Approach” to reduce AMR’s impact on vulnerable populations and foster healthier communities. Afya Plus is proud to lead and set the standard for community-based AMR prevention efforts in our country, striving for a healthier future for all. #AntimicrobialResistance #ReduceTheBurdenofAMR #PeopleCenteredAMRResponse #QualityHealthServiceForEveryone

#Antimicrobialresistance(AMR) threatens our future. Antimicrobials are drugs – such as antibiotics – that kill or control disease-causing microbes. Antimicrobial resistance (#AMR) occurs when microbes mutate or adapt in ways that enable them to withstand antimicrobials, rendering treatments ineffective. AMR is dramatically accelerated by the over-use and misuse of antimicrobials, including antibiotics, in people and animals. In 2019, #drug-resistant infections were a significant contributor to mortality, with around 5 million people losing their lives due to such #infections. Out of these deaths, almost 1.3 million were directly attributable to AMR. The impact of AMR is not limited to human health. In 2017, the The World Bank estimated that by 2050, unchecked AMR could wipe away 3.8 % of global gross domestic product each year and push 28 million people into poverty. The world’s poorest people –those living in low- and middle-income countries(#LMICs) are disproportionately vulnerable. Simple interventions like improving #infectionprevention and control in health care settings is going to have significant impact on this silent pandemic-#AMR. 📢#Join us for the #IPC Awareness Campaign! With this campaign, We will promote effective #IPC interventions/measures in healthcare and general public to reduce #infections and combat #AMR. ‼️Together, Let's act to promote #InfectionPrevention and #PublicHealth in our community. #Infectionpreventionandcontrol #ActOnAMR #OneHealth #Rwanda #Antimicrobialresistance #StopAMR

The sobering findings from this Lancet study on antibiotic resistance in India underscore the devastating human toll of the global AMR crisis. With 39 million lives potentially at risk over the next 25 years, it's clear that urgent action is needed on multiple fronts. Promoting antibiotic stewardship programs in healthcare settings, investing in new antimicrobial drug development, and educating the public on appropriate antibiotic use are all critical strategies to combat this mounting public health emergency. Policymakers, clinicians, researchers, and communities must work together to implement evidence-based interventions and prevent further spread of drug-resistant infections. What innovative solutions are you seeing or implementing to preserve the efficacy of these life-saving drugs and protect vulnerable populations? This is a global challenge that requires a coordinated, multi-stakeholder response. #AntibioticResistance #AMR #GlobalHealth #PublicHealth #PatientSafety #DrugResistance #MedicalInnovation #HealthcareSolutions #ScienceMatters #SavingLives

"Antimicrobial Resistance (AMR) is one of the most pressing public health threats of our time. Every year, millions of people suffer from infections that no longer respond to the medicines we have relied on for decades. Once curable diseases are becoming untreatable, leading to prolonged illness, increased mortality, and soaring healthcare costs. The overuse and misuse of antibiotics, in both human medicine and agriculture, have accelerated this crisis, giving bacteria, viruses, fungi, and parasites a chance to evolve and resist the effects of drugs designed to eliminate them. But AMR is not an inevitable part of the future—it is something we can change through action today. To fight this, we must use antibiotics responsibly: only when prescribed by healthcare professionals, and only for the full course of treatment. At the same time, healthcare providers must commit to better stewardship, ensuring that antibiotics are prescribed only when absolutely necessary. Governments, health institutions, and individuals all have a role to play. We need stronger policies to regulate antibiotic use, greater investment in research for new medicines, and increased public awareness about the consequences of misusing antibiotics. This is not just a fight for health professionals—this is a call for every individual to take responsibility in protecting the effectiveness of antibiotics for future generations. Together, we can curb AMR by taking the right steps now. It starts with awareness, followed by action. The future of modern medicine depends on it. #AMR #AntibioticAwareness #GlobalHealth #Stewardship"

Ahead of the World Health Assembly (#WHA77) next week, The Lancet has published a series of papers on 'Sustainable Access to Effective Antibiotics'.     I'm proud to have contributed to this important work that highlights the urgent need for global action on antimicrobial resistance (AMR): hubs.li/Q02xnk7n0   AMR is one of the greatest health challenges of our time. It threatens us all, however the most vulnerable are at the most risk.     If we don't prioritise action now, we will see a steady increase in the global death toll.    This week, we shared Wellcome Trust's recommendations for driving more ambitious action on AMR:  1. set a bold, unifying goal for reducing AMR  2. create a panel for scientific evidence and action  3. establish mechanisms to regularly review progress    High-level political events this year present a unique opportunity for global leaders to unite in a more effective, collective response to AMR.    To improve health and save lives, it must be informed by scientific evidence and establish clear targets and governance.    You can read more in our policy brief. https://lnkd.in/etawaiGc

Check out this eye-opening infographic from The Lancet, highlighting the "enormous, growing, and unevenly distributed" impact of Antimicrobial Resistance (AMR). The data underscores the urgent need for global action and innovation to tackle this escalating health crisis. #AMR #HealthCrisis #Innovation #GlobalHealth #Infectioninfocus

🦠 Antimicrobial Resistance (AMR): A Silent Global Threat 🌍 Antimicrobial resistance is one of the most pressing health challenges of our time, with the potential to undo decades of medical progress. When bacteria, viruses, fungi, and parasites evolve to resist the drugs designed to kill them, we face infections that are harder—and sometimes impossible—to treat. 💡 Why Should We Care? 1. Global Impact: AMR could cause 10 million deaths annually by 2050 if no action is taken. 2. Economic Burden: The cost of treating resistant infections is significantly higher, straining healthcare systems worldwide. 3. Everyday Relevance: From routine surgeries to chemotherapy, our reliance on effective antimicrobials is profound. Without them, even minor infections can become life-threatening. 📢 What Can We Do? 1.Educate: Spread awareness about the dangers of misuse and overuse of antibiotics. 2.Innovate: Support research in new antimicrobial agents, vaccines, and alternative therapies. 3.Advocate: Promote policies that encourage responsible use of antibiotics in humans, animals, and agriculture. Let's all play our part in combating this global threat. Together, we can preserve the efficacy of life-saving drugs and ensure a healthier future for all. #AntimicrobialResistance #AMR #PublicHealth #Healthcare #GlobalHealth #Innovation Woxsen University Daya Shankar Tiwari Beauty Pandey Dr. Ramakrishna Madaka Dr. Dipak Kumar Sahoo Dr T Santhosh Kumar Bikram Bikash Das Dr. Shouvik C. vishal anand Dr.Madhuri Pola Dr Srikar Thota Dr. Sudarshana Santhosh Kumar Kothapalli

Global and National Efforts to Combat Antibiotic Resistance 🔬 Organizations around the world are taking critical steps to address the growing threat of antibiotic resistance. Key initiatives include: - **World Health Organization (WHO)**: The Global Action Plan on Antimicrobial Resistance focuses on improving awareness, strengthening surveillance, and promoting the prudent use of antimicrobials. - **Indian Council of Medical Research (ICMR)**: ICMR's Antimicrobial Resistance Surveillance & Research Network (AMRSN) monitors resistance patterns, guides policy development, and supports research to find new treatment options in India. - **Infectious Diseases Society of America (IDSA)**: IDSA's "10 x '20" initiative aims to develop 10 new antibiotics by 2020, pushing for innovation and stewardship in antimicrobial therapy. These efforts are crucial in the global fight against antibiotic resistance. We must support and amplify these initiatives to ensure a healthier future. #WHO #ICMR #IDSA #AntibioticResistance #GlobalHealth #AMR #PublicHealth

🌍 Join us virtually for the premiere of the 2024 The Lancet series on #AMR! The global fight for better health outcomes and decades of progress in treating infections are at risk due to antimicrobial resistance (AMR). The United Nations General Assembly (UNGA) will hold a high-level meeting in September 2024 to discuss this present and growing threat. To bolster the momentum gained from this watershed moment in the battle to control AMR, a Lancet series was commissioned to provide crucial data, evidence, and policy recommendations to serve as the cornerstone for a U.N. resolution addressing AMR. In the series, we touch on the current burden of AMR, the importance of expanding antibiotic access and innovation, and the need to promote the establishment of global targets and get politicians on board. To commemorate the series, #OneHealthTrust, #FIND,  #IFPMA, #ICARS, #AMRActionFund, #AfricaCDC, GlobalAMR R&D Hub, and #IDSA are holding a symposium, gathering authors, experts, policymakers, and civil society to discuss AMR's impact, the importance of antibiotic access, and the push for global targets. While the in-person event is invitation-only, catch the live stream to be part of this vital conversation! Register here: https://lnkd.in/eN2WPZEP Date and time: May 28, 6:30 PM - 8:30 PM (GMT+2, Geneva, Switzerland)

A people-centred approach to tackling antimicrobial resistance (#‎AMR)‎ was developed by the WHO Regional Office for Europe to support countries in their implementation of the recently adopted Roadmap on antimicrobial resistance for the WHO European Region 2023–2030. A people-centred approach acknowledges the central role of individuals and communities in tackling AMR, and in helping to address weaknesses and gaps in current AMR efforts. The document illustrates what a people-centred approach to AMR means, demonstrates its value, and compiles useful resources and tools for implementation. https://lnkd.in/dn558CK4 Robb Butler, Keti (Ketevan) Kandelaki, Nieves Ehrenberg, Katrine Bach Habersaat, Tiina Likki, Tine Rikke Jorgensen, Viktoria Stein, PhD, Sarah Paulin-Deschenaux, Nienke van de Sande-Bruinsma, PhD, Kitty van Weezenbeek, Anand Balachandran, Bassem Zayed, Stephanie Brickman, Dr. Pilar Ramon-Pardo, Nathalie El Omeiri, Yahaya ALI AHMED, Takeshi Nishijima, Geraldine Hill, Ansshu Butani, Ana Paula Coutinho Rehse, Peter Sousa Hoejskov, @Oliver Schmoll, Joanna Salvi Le Garrec, Kotoji Iwamoto, Sarah Garner, Valentina Grossi, Marcello Gelormini, Karen Taksøe-Vester, Jodie Littlewood.